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http://www.retrovirology.com/content/11/1/112RESEARCH Open AccessPlasmodium infection reduces the volume of the
viral reservoir in SIV-infected rhesus macaques
receiving antiretroviral therapy
Xiao-Yong Zhan†, Nina Wang†, Guangjie Liu, Limei Qin, Wanwan Xu, Siting Zhao, Li Qin* and Xiaoping Chen*Abstract
Background: Previous studies indicated that Plasmodium infection activates the immune system, including memory
CD4+ T cells, which constitute the reservoir of human immunodeficiency virus type-1 (HIV-1). Therefore, we postulated
that co-infection with malaria might activate the reservoir of HIV-1. To test this hypothesis, we used a rhesus macaque
model of co-infection with malaria and simian immunodeficiency virus (SIV), along with antiretroviral therapy (ART).
Results: Our results showed that Plasmodium infection reduced both the replication-competent virus pool in resting
CD4+ T cells and the integrated virus DNA (iDNA) load in peripheral blood mononuclear cells in the monkeys. This
reduction might be attributable to malaria-mediated activation and apoptotic induction of memory CD4+ T cells.
Further studies indicated that histone acetylation and NF-kappaB (NF-κB) activation in resting CD4+ T cells may also
play an important role in this reduction.
Conclusions: The findings of this work expand our knowledge of the interaction between these two diseases. As more
HIV-1-infected individuals in malaria-endemic areas receive ART, we should explore whether any of the patients
co-infected with Plasmodium experience virologic benefits.
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Human immunodeficiency virus type-1 (HIV-1) infection is
one of the most important global health problems [1]. The
virus replicates within and destroys CD4+ T cells in pa-
tients, ultimately leading to acquired immune deficiency
syndrome (AIDS). Antiretroviral therapy (ART) can dra-
matically control the replication of HIV-1 and decrease
viral loads in HIV-1-infected individuals. Many HIV-1-
positive individuals have recently begun receiving ART in
low- and middle-income regions. The pool of resting CD4+
T cells, including CD4+ central memory T (TCM) and ef-
fector memory T (TEM) cells, is a major reservoir because
ART does not affect the provirus within these cells [2,3].
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unless otherwise stated.HIV-1 [2,3]. As a result, one of the major therapeutic strat-
egies for eradication of the HIV-1 reservoir is to reactivate
the latent provirus in resting CD4+ T cells [4]. This strategy
is promising for purging HIV-1 from this reservoir.
Malaria is another important infectious disease, and it
has been shown to strongly activate the immune system
[5]. In particular, Plasmodium antigens can activate T cells
via antigen-presenting cells (APCs) [5], and polyclonal ac-
tivated T and B cells, including memory CD4+ T cells, are
observed during the blood stage of Plasmodium infection
in mice and monkeys [6-8].
Previous studies have suggested that malaria has effects
on HIV-1 infection [9-12]. Specifically, malaria infection
might strongly activate CD4+ T cells; up-regulate proin-
flammatory cytokines, such as interleukin-6 (IL-6) and
tumor necrosis factor-alpha (TNF-α); and induce activa-
tion of the virus [9,13,14]. However, ART may control
HIV-1 replication in CD4+ T cells, even during malaria in-
fection. We therefore hypothesized that the impact of mal-
aria on HIV-1 infection under ART might be different
from the impact in those situations without ART. Moretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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activate latently infected resting CD4+ T cells and induce
latent virus reactivation, thus reducing the volume of the
viral reservoir under ART.
To test our hypothesis, we utilized a rhesus macaque
model of co-infection with Plasmodium cynomolgi (Pc, a
nonlethal monkey malaria Plasmodium species) and sim-
ian immunodeficiency virus (SIVmac251, SIV) under ART.
As expected, malaria activated the CD4+ T cells, decreased
the integrated virus DNA (iDNA) load in peripheral blood
mononuclear cells (PBMCs) and reduced the replication-
competent virus pool in resting CD4+ T cells. We also
found increased levels of apoptotic memory CD4+ T cells
during the course of Pc infection. Additionally, malaria in-
duced histone acetylation and activation of NF-kappaB
(NF-κB) in resting CD4+ T cells. All of these factors might
contribute to the reduction of the viral reservoir.
Results
Pc infection reduced the size of the viral reservoir in
SIV-infected macaques
The design of the animal experiments is shown in Figure 1.
Twelve Chinese-origin rhesus macaques (Macaca mulatta)
were inoculated intravenously with 10,000 50% tissue
culture infectious doses of SIVmac251 and were randomly
divided into two groups (n = 6 per group): the ART group
(ART only) and the ART+ Pc group (ART plus Pc
infection). SIV infection resulted in certain typical viro-
logical and immunological changes in the monkeys that
were similar to those reported previously (Additional file 1:
Figure S1) [15]. The animals in the ART+ Pc group dis-
played typical clinical manifestations of malaria during Pc
infection (data not shown).
Pc infection significantly decreased the frequency of rest-
ing CD4+ T cells harboring replication-competent virus
(defined as infectious units per million cells, or IUPM)
(Figure 2A and B, Table 1). After the malaria was treated,Figure 1 Animal study design. At week 0, 12 monkeys in the 2 groups w
(downward black arrow). During weeks 49–66, 6 monkeys in the ART + Pc
was terminated in all monkeys (upward black arrow). The light gray boxesthe IUPM in the ART + Pc group remained significantly
lower at weeks 68 and 73 compared with the IUPM in the
ART group before ART was terminated (“No-malaria
phase,” as shown in Figure 1; P = 0.001; Figure 2B). The
ART + Pc group also showed a lower iDNA load in
PBMCs after Pc infection (under ART) compared with the
load in the ART group (means of 0.23 and 1.11 copies per
105 PBMCs, respectively; P = 0.047; Figure 2C). These re-
sults suggested that under ART, Pc infection decreased the
viral reservoirs in SIV-infected macaques.
Pc infection increased the apoptosis of memory CD4+ T
cells
Induction of memory-cell apoptosis potentially leads to re-
duction of SIV reservoirs in rhesus macaques [16]. To de-
termine whether Pc infection affects CD4+ TCM and TEM
cell viability, we measured the percentages of CD4+ TCM
and TEM cells with annexin V expressed on the cell mem-
brane. The marker Ki67 was also used to evaluate the pro-
liferation of these cells. CD28 + CD95 + CD4+ T cells were
defined as CD4+ TCM cells, CD28 + CD95-CD4+ T cells
were defined as CD4+ TEM cells in rhesus macaques ac-
cording to previously report [17]. Our results suggested
that Pc infection did not increase the proliferation levels of
CD4+ TCM and TEM cells (data not shown). However, the
apoptosis levels of CD4+ TCM cells in the ART + Pc group
were higher than those in the ART group during the mal-
aria phase (especially during the acute phase, from weeks
49–53; means of 8.25% and 6.56%, respectively; P = 0.12;
Figure 3A). There were also significantly more apoptotic
CD4+ TEM cells in the ART + Pc group than in the ART
group (means of 12.09% and 7.46%, respectively; P = 0.046;
Figure 3B). We also observed that the number of iDNA
copies in PBMCs during the malaria phase was nega-
tively correlated with the apoptosis levels of CD4+ TCM
cells in the two groups (P = 0.025, r = −0.372; Figure 3C).
Additionally, the number of iDNA copies was negativelyere infected with SIV. At week 15, all monkeys started to receive ART
group were co-infected with Pc (red arrows and box). At week 75, ART
indicate ART, and the light red box indicates Pc infection.
Figure 2 The impact of Pc infection on the SIV reservoir. (A) A significantly reduced frequency of resting CD4+ T cells harboring replication-
competent SIV was observed during malaria infection in the ART + Pc group. Four of 6 monkeys in the ART + Pc group maintained less than 0.51 IUPM
during the malaria phase, whereas all 6 monkeys in the ART group maintained an IUPM value above or equal to 0.51. The IUPM values in the two
groups of monkeys were significantly different during the malaria phase. (B) The fitted curve revealed dynamic changes in IUPM in the two groups
during the study. Each arrow has the same meaning as indicated in Figure 1. (C) Dynamic plots of iDNA in PBMCs at each time point. The copy number
was significantly reduced after Pc infection in the ART + Pc group (under ART) compared with the ART group (1.11 ± 6.76 vs. 0.23 ± 10.05 copies/105
PBMCs). The meaning of each arrow is the same as indicated in Figure 1. Fisher’s exact test was utilized to examine the difference in IUPM between the
two monkey groups. The numbers of SIV iDNA copies at weeks 51, 54 and 73 in the PBMCs of monkeys in the same group were combined to examine
the differences between the two groups. The Mann–Whitney U test was utilized. Empower (R) (www.empowerstats.com, X&Y Solutions, Inc., Boston,
MA) and R (http://www.R-project.org) were used for smooth curve fitting.
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(P = 0.11, r = −0.270, respectively; Figure 3D). These re-
sults suggested that the reduction of the viral reservoir in
the ART + Pc group might have been associated with the
increased levels of CD4+ TCM and TEM cell apoptosis dur-
ing the course of malaria.
Pc infection selectively activated the immune system in
SIV-positive monkeys under ART, which potentially led to
memory CD4+ T cell apoptosis and a reduction of the SIV
reservoir
Our previous study using the rhesus monkey model
indicated that Pc infection activated CD4+ T cells inSIV-negative animals [7]. In the present study, we examined
activation markers of CD4+ T cells in SIV-positive animals
under ART, including HLA-DR and CD38 co-expression
on CD4+ T cells and plasma cytokine concentrations.
Malaria did not increase the concentrations of plasma cy-
tokines such as TNF-α, interleukin-7 (IL-7), interleukin-2
(IL-2, represented by its activity marker, the IL-2 receptor,
or IL-2R) and IL-6, which have been shown to promote
provirus reactivation [18-21] and to represent activation of
the immune system (Additional file 2: Figure S2A). How-
ever, CD4+ T cell activation was found in the ART + Pc
group because a greater percentage of HLA-DR+CD38 +
CD4+ T cells, which is a robust measure of CD4+ T cell
Table 1 Resting CD4+ T cells’ IUPM for each monkey
Monkey grouping
and ID
Phase, week post-SIV inoculation, and IUPM
ART phase Malaria phase No-malaria phase
Week 43 Week 46 Week 58 Week 63 Week 68 Week 73
ART 26 1.6 0.51 1.6 1.6 1.6 0.51
28 0.51 0.51 1.6 1.6 0.51 1.6
30 0.51 0.51 1.6 1.6 1.6 0.51
32 3.2 3.2 1.6 1.6 0.51 1.6
34 1.6 1.6 1.6 1.6 * 0.51
36 1.6 1.6 0.51 0.51 3.2 1.6
ART + Pc 27 3.2 1.6 0.51 0.51 * <0.51
29 0.51 0.51 <0.51 <0.51 0.51 0.51
31 1.6 1.6 <0.51 <0.51 0.51 <0.51
33 3.2 3.2 1.6 0.51 <0.51 <0.51
35 1.6 1.6 <0.51 <0.51 <0.51 0.51
37 3.2 0.51 <0.51 <0.51 0.51 <0.51
*Sorted resting CD4+ T cells were insufficient for co-culture assays; therefore, no data were obtained. The detection limit was 0.51, and IUPM values less than the
detection limit are indicated as “<0.51” or defined as the most likely largest value (0.32) to formulate the fitted curve in Figure 2B.
Figure 3 Pc infection induced CD4+ TCM and TEM cell apoptosis during the malaria phase. (A) During the malaria phase, the apoptosis
level of CD4+ TCM cells in the ART + Pc group was higher than that in the ART group, especially during acute malaria (weeks 49–53), although
this difference was not significant (10.24 ± 7.34% vs. 6.98 ± 3.77%, P = 0.12; perhaps the limited significance was a result of the small number of
monkeys). (B) Pc infection induced higher levels of apoptosis of CD4+ TEM cells throughout the malaria phase (12.09 ± 10.58% vs. 7.46 ± 6.81%).
(C) A negative correlation was noted between the percentage of apoptotic CD4+ TCM cells and the SIV iDNA load in PBMCs during the malaria
phase. (D) An approximate negative correlation was noted between the percentage of apoptotic CD4+ TEM cells and the SIV iDNA load in
PBMCs during the malaria phase. Variables at different time points in the same phase and group were combined for statistical analyses. The
Mann–Whitney U test was utilized. Pearson’s correlation analysis was used to analyze the relationship between the parameters tested in C and D.
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trations of plasma neopterin (an activity marker of
interferon-gamma, or IFN-γ) were also observed in the
ART + Pc group during malaria infection (Additional
file 2: Figure S2B). There was a significant positive correl-
ation between plasma neopterin levels and the percentage
of HLA-DR + CD38 + CD4+ T cells during the malaria
phase (P = 0.002; r = 0.493; Additional file 2: Figure S2C),
suggesting that the activation of CD4+ T cells was associ-
ated with higher concentrations of neopterin induced by
malaria. Moreover, the CD4+ T cell activation level, as in-
dicated by the percentage of HLA-DR +CD38 + CD4+ T
cells, was shown to be positively correlated with the
percentage of annexin V +CD4+ TCM and TEM cells dur-
ing the malaria phase (P = 0.031, r = 0.44 and P = 0.050,
r = 0.404; respectively; Figure 4B and C). The CD4+ T cell
activation level during the malaria phase was also
negatively correlated with the iDNA levels in PBMCs
(P = 0.005, r = −0.458; Figure 4D). Additionally, a greater
percentage of CCR5 + CD4+ T cells, which have also beenFigure 4 The activation of CD4+ T cells during malaria infection pote
leading to a reduction of the SIV reservoir. (A) Pc infection induced the
the activation of these cells (1.97 ± 1.47% vs. 1.00 ± 0.61%). (B) A significant
CD38 + CD4+ T cells and the percentage of apoptotic CD4+ TCM cells durin
correlation was noted between the percentage of HLA-DR + CD38 + CD4+
malaria phase in the two groups of monkeys. (D) A significant negative correl
cells and the SIV iDNA load in PBMCs. The percentages of HLA-DR + CD38 + C
combined to examine the difference between the two groups; the Mann–Wh
Spearman’s correlation analysis was used to analyze the relationship betweenlinked to the activation of CD4+ T cells and the immune
system [22,23], was observed in the ART + Pc group dur-
ing malaria infection (Additional file 2: Figure S2D). These
results suggested that malaria activated CD4+ T cells,
which might have led to the apoptosis of certain CD4+
TCM and TEM cells and contributed to the reduction of
the SIV reservoir.Pc infection induced histone acetylation in latently
SIV-infected resting CD4+ T cells and reactivated the
provirus in these cells
Previous studies showed that histone acetylation in
resting CD4+ T cells could induce reservoir purging
[24,25]. We thus examined the histone acetylation levels
in peripheral blood lymphocytes (PBLs) in the monkeys
during different phases. The results showed that the
levels of global histone acetylation in PBLs, as measured
based on mean fluorescence intensity (MFI), were much
higher in the ART + Pc group during Pc infection thanntially resulted in the apoptosis of CD4+ TCM and TEM cells,
co-expression of HLA-DR and CD38 in CD4+ T cells, which indicated
positive correlation was noted between the percentage of HLA-DR +
g the malaria phase in the two groups of monkeys. (C) A positive
T cells and the percentage of apoptotic CD4+ TEM cells during the
ation was noted between the percentage of HLA-DR + CD38 + CD4+ T
D4+ T cells at different time points in the same phase and group were
itney U test was utilized, and the data are shown as the mean ± SD.
the parameters tested in C and D.
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P = 0.001; Figure 5A–C).
We further explored whether the products of malaria
parasites participated in the purging of the viral reservoir.
A chloroquine-sensitive strain (3d7) and a chloroquine-
resistant strain (dd2) of the human malaria parasite
Plasmodium falciparum (Pf) were used for these tests. In
particular, we prepared the Pf 3d7 metabolite hemozoin
(HZ) and soluble extracts to test their potencies in reacti-
vating latent cells. An in vitro assay was then performed
with J-Lat 10.6 cells to determine whether Pf HZ or sol-
uble extract could reactivate these latently infected CD4+
T cells by observing the expression of HIV-1-pseudotyped
virus. The results showed that 5 μg/ml Pf soluble extract
could reactivate the J-Lat 10.6 cells. Increased GFP ex-
pression after 24–48 hours of co-incubation was observed,
indicating the expression of latent virus. However, 10–
100 μg/ml HZ did not activate the J-Lat 10.6 cells
(Figure 6A). Additionally, valproic acid (VPA) and phyto-
hemagglutinin (PHA) were used as positive controls. Both
compounds induced the expression of latent virus in J-Lat
10.6 cells, but only VPA induced more acetylated histones
(Figure 6B). Fluorescence-activated cell sorting (FACS)
assays also showed that 5 μg/ml Pf soluble extract could
induce more histone acetylation in J-Lat 10.6 cells after
24- or 48-hour co-incubation. In resting CD4+ T cells iso-
lated from the PBMCs of the SIV-infected monkeys,
50 μg/ml Pf soluble extract could also induce histone
acetylation after a 24- or 48-hour co-incubation (Figure 6C).
In contrast, 1 μg/ml Pf soluble extract did not induce much
more histone acetylation in J-Lat 10.6 cells (Additional
file 3: Figure S3), and 25 μg/ml Pf soluble extract dramatic-
ally induced the death of J-Lat 10.6 cells (data not shown).Figure 5 Flow cytometric quantitation of the histone acetylation leve
monkeys. (A) Lymphocytes gated by size on a forward scatter vs. side sca
representative flow cytometric analyses of different histone acetylation leve
measuring the fluorescence intensity of these cells. The figure presents the
groups at week 54 (5 weeks after Pc infection). (C) Higher histone acetylati
Pc infection (MFI of 188.90 ± 51.33 at week 54 vs. 125.96 ± 20.80 at week 5
combined to examine the difference in acetylated histone levels between
was utilized for statistical analyses. The data are shown as the mean ± SD.Unlike the situation in J-Lat cells, 50 μg/ml Pf soluble ex-
tract could sufficiently induce significantly more histone
acetylation in the monkey resting CD4+ T cells (Additional
file 3: Figure S3). These results indicated that the sensitiv-
ity of the J-Lat cell line and primary monkey cells to Pf ex-
tract was not the same.
Chromatin immunoprecipitation (ChIP) assays showed
that the amounts of acetylated histone H3 (AcH3)
bound to the core promoter region within the HIV-
1 and SIV long terminal repeats (LTRs) increased
when cells were co-incubated with Pf soluble extract
Figure 6D and E). In particular, in J-Lat 10.6 cells, the
acetylated histone levels increased 1.65-fold when the
cells were stimulated with Pf 3d7 extract and increased
3.07-fold when the cells were stimulated with Pf dd2
extract. In contrast, in monkey PBMCs, the levels in-
creased 3.10-fold with Pf 3d7 extract and 2.30-fold with
Pf dd2 extract after a 24-hour co-incubation (Figure 6D
and E).
Pc infection might activate the NF-κB signaling pathway
in latently infected CD4+ T cells
Given that previous studies demonstrated that NF-κB
activation was associated with provirus reactivation
[26,27], we investigated NF-κB translocation in monkey
PBMCs in selected phases. This experiment used im-
munofluorescence confocal microscopy to assess the ac-
tivation level of NF-κB. The percentage of NF-κB+ cells
was significantly higher in the PBMCs of monkeys in the
ART + Pc group during Plasmodium infection compared
with the percentage in the ART group (means of 16.23%
and 9.69%, respectively; P < 0.001; Figure 7A and B).
This result suggested that the NF-κB signaling pathwayls in lymphocytes from different phases in the two groups of
tter plot. (B) Two monkeys were selected from different groups for
ls. The acetylated histone levels of the gated cells were analyzed by
difference in the lymphocytes’ acetylation levels in the different
on levels were observed in lymphocytes in the ART + Pc group during
7). MFI values from weeks 54 and 57 in the same group were
the two groups during the malaria phase. The Mann–Whitney U test
Figure 6 (See legend on next page.)
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Figure 6 In vitro assays measuring activation and histone acetylation of the HIV-1 or SIV promoter by Pf extracts. (A-B) The effects of
the synergistic activation of the HIV-1 promoter were determined by quantifying GFP-positive cells using flow cytometry 24 or 48 hours after
treatment. (A) In total, 5 μg/ml Pf soluble extract induced HIV-1 promoter activation in J-Lat cells, leading to GFP expression. (B) Both PHA and
VPA induced activation of the HIV-1 promoter in J-Lat cells and subsequent GFP expression. In contrast, PHA did not induce increased levels of
histone acetylation in J-Lat cells, whereas VPA induced histone acetylation. (C) 5 μg/ml Plasmodium soluble extract increased histone acetylation
levels in J-Lat cells, and 50 μg/ml Plasmodium soluble extract was sufficient to induce increased levels of histone acetylation in resting CD4+ T
cells. This result was obtained from FACS assays. (D-E) Histone acetylation modifications in the HIV-1 LTR and SIV LTR promoters induced by
Plasmodium soluble extract. Chromatin fragments from J-Lat cells or monkey PBMCs cultured for 24 hours with or without Plasmodium soluble
extract or VPA were immunoprecipitated with anti-AcH3 or with normal rabbit serum (IgG) as a control. PCR was then used to amplify the DNA
isolated from the immunoprecipitated chromatin. The relative dilution ratio of input/chip was 1.33. (D) Pf soluble extract induced an increase in
the histone acetylation levels in the HIV-1 LTR. (E) Pf soluble extract induced an increase in the histone acetylation levels in the SIV LTR. The left
panels of D and E show semi-quantitative results based on PCR products using input DNA, normal IgG control product or 24-hour CHIP product
as the template. The data in this figure are presented as the means, and the error bars indicate the SD. One-way ANOVA was used to compare
the variables in this figure.
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by malaria. An in vitro culture assay also indicated that
5 μg/ml or 50 μg/ml Plasmodium extract could induce
NF-κB activation in J-Lat cells and monkey PBMCs
(Figure 7C and D).Figure 7 In vivo and in vitro assays for NF-κB activation. (A–B) An in vivo
infection. In particular, PBMCs were isolated from monkeys in the two groups
nuclear staining and classified them as cells with NF-κB activation. (A) NF-κB n
the activation of NF-κB in PBMCs. DAPI staining was used to identify the nucle
NF-κB-positive nuclei in PBMCs. These cells were considered to contain activa
activation in PBMCs during malaria infection, as indicated by the percentages
The data in this figure are presented as the means, and the error bars show th
associated with malaria that activate NF-κB. PBMCs isolated from monkeys we
activation in the cells was then measured by ELISA. (C) Pf soluble extract indu
4-hour incubation. (D) Pf soluble extract induced an increase in activated NF-κB
of NF-κB+ PBMCs at different time points of the same phase in the same group
utilized to examine the difference in this parameter between the two groups. O
this figure are presented as the means, and the error bars indicate the SD.Memory CD4+ T cell activation, apoptosis and latent virus
reactivation induced by Pc infection were partly
associated with Plasmodium extract stimulation
Our in vivo study showed that Plasmodium infection
caused CD4+ T cell activation and might have led to theassay as performed to measure NF-κB activation levels during malaria
at different time points for each phase. We counted the cells with NF-κB
uclear transport was measured by immunofluorescence to determine
ar region to assess gross cell morphology. The white arrows show the
ted NF-κB. (B) The ART + Pc group maintained higher levels of NF-κB
of NF-κB-positive nuclei in the PBMCs (16.23 ± 3.12% vs. 9.69 ± 1.74%).
e SD. (C-D) In vitro assays were performed to detect specific factors
re stimulated with Pf extract or 25 ng/ml PHA plus 1 μg/ml LPS. NF-κB
ced an increase in activated NF-κB in J-Lat cells at 5 μg/ml after a 2- or
in RM PBMCs at 50 μg/ml after a 2- or 4-hour incubation. The percentages
were combined for statistical analyses. The Mann–Whitney U test was
ne-way ANOVA was used to compare the variables in C and D. The data in
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iDNA load in PBMCs. The in vitro study also showed
that Plasmodium extract could activate latently infected
J-Lat 10.6 cells and cause the expression of latent virus
(Figure 6A). To test the potency of Plasmodium extract
in activating latently SIV-infected memory CD4+ T cells
and inducing the apoptosis of these cells, we performed
an in vitro assay in which PBMCs from a chronically
SIV-infected monkey were treated with different concen-
trations of Pf 3d7 or dd2 extract.
Figure 8A and B show the potency of Pf 3d7 extract in
inducing the activation and apoptosis of monkey mem-
ory CD4+ T cells. The results showed that Pf extract
could induce the apoptosis of memory CD4+ T cells and
the activation of these cells. Specifically, more expression
of the activation marker CD38 and HLA-DR was found
after co-incubation with Pf extract (Figure 8A and B).
Correlation analysis showed that the apoptosis of mem-
ory CD4+ T cells positively correlated with the activation
level of these cells (Figure 8C). Pf dd2 extract had simi-
lar potency in inducing the activation and apoptosis of
monkey memory CD4+ T cells (data not shown). In
addition, more expression of the SIV antigen p27 protein
was induced after 8 days of culture with Pf extract
(Figure 8D).
Discussion
Because malaria infection can induce CD4+ T cell activa-
tion and lead to the replication of HIV-1 in patients with-
out ART [9], we postulated that malaria might activate
resting CD4+ T cells, thereby promoting HIV-1 transcrip-
tion and replication. This viral reactivation would then
purge the HIV-1 reservoir in patients undergoing ART.
We utilized a monkey model to test this hypothesis.
Rhesus macaques provide an ideal model for HIV-1 and
malaria infection in humans [28-30]. SIV-infected rhesus
macaques have revealed key aspects of HIV-1 patho-
genesis, such as virus transmission, early post-infection
events, the sites of viral replication, CD4+ T cell depletion,
and virus and cell turnover [31], and these animals have
been utilized in studies of viral reservoirs [16]. Compared
with Chinese rhesus macaques, the Indian rhesus ma-
caque model has limitations [32,33]; SIV pathogenesis in
Chinese rhesus macaques more closely resembles HIV-1
infections in humans [34]. Beyond P. cynomolgi (Pc), two
other malaria parasites, Plasmodium knowlesi and Plasmo-
dium coatneyi, which can also infect rhesus macaques, are
fulminating in rhesus macaques and nearly always result
in death [35]. Thus, we utilized Pc and SIVmac251 co-
infection in Chinese rhesus macaques to mimic HIV-1
and malaria co-infection in humans.
Malaria infection can increase the plasma viral load in
HIV-1-infected individuals and in monkey models without
ART [9,14]. In the present study, the ART+ Pc groupshowed a 0.27-log higher plasma viral load during malaria
infection compared with the load in the ART group (2.01
log vs. 1.74 log; P = 0.090; Additional file 1: Figure S1D). Be-
cause the iDNA level in PBMCs was lower in the ART+ Pc
group during malaria infection, this small change in plasma
virus levels might not have been derived from viral replica-
tion in pre-existing activated CD4+ T cells or in newly in-
fected CD4+ T cells, which are both susceptible to SIV
because of the higher level of CCR5 expression on CD4+ T
cells (Additional file 2: Figure S2D). This result also sug-
gested that the ART regimen in this study effectively
blocked SIV entry into these susceptible cells. A reasonable
explanation is that this small increase in virus levels might
have been derived from the activation of latently infected
cells, which was reflected by our in vivo finding that malaria
increased the activation level of CD4+ T cells (Figure 4A)
and our in vitro finding that Plasmodium extract could in-
duce activation of the main cellular reservoir, the memory
CD4+ T cells (Figure 8B). The higher levels of IFN-γ activ-
ity (represented by higher levels of plasma neopterin) in-
duced by malaria also indicated immune system and T cell
activation [13]. The higher levels of neopterin induced by
malaria especially indicated the activation of macrophages
[36], which may be more critical in the process of SIV res-
ervoir purging because Van der Sluis et al. have shown that
APCs such as myeloid dendritic cells can activate latent T
cells more than other T cell activators do [37]. A correlation
analysis of plasma neopterin and the activation level of
CD4+ T cells might also have uncovered this phenomenon
(Additional file 2: Figure S2D). In contrast to neopterin,
neither the expression of the other cytokines tested, in-
cluding IL-2, IL-6, IL-7 and TNF-α, nor their activities
increased during malaria infection under ART (i.e., there
were no differences between the two groups; Additional
file 2: Figure S2A), indicating that ART potentially alters
the interaction of SIV and the malaria parasite in vivo.
The activation of resting CD4+ T cells could facilitate
the apoptosis of these cells [38,39]. Malaria infection spe-
cifically induces apoptosis in mononuclear cells, including
memory T cells, and contributes to reduction of the im-
mune response to critical antigens [40]. This effect was
also observed in the ART + Pc group (Figure 3A and B)
and in our in vitro assay (Figure 8A). However, due to the
relatively small number of animals in the present study,
we did not observe a significant effect of malaria on CD4+
TCM cell apoptosis, but monkeys that were co-infected
with malaria did maintain a relatively higher level of
apoptotic CD4+ TCM cells (Figure 3A). Moreover, the ef-
fect of malaria on CD4+ TEM cell apoptosis was significant
(Figure 3B). We also observed significantly high levels of
apoptotic memory cells induced by Pf extract in our
in vitro study (Figure 8A). These results indicated that
malaria did induce the apoptosis of memory CD4+ T cells,
which were the main cellular reservoir of SIV. It is
Figure 8 In vitro assays measuring the apoptosis and activation of monkey memory CD4+ T cells by Pf extract. PBMCs from a monkey with
chronic SIV infection were isolated and cocultured with Pf extract. After coculture for 24 or 48 hours, the cells were stained with anti-CD4 PE-Cy7,
anti-CD95-APC, and annexin V PE or with anti-CD4 PE-Cy7, anti-CD95 APC, anti-CD38 FITC and anti-HLA-DR PE. Memory CD4+ T cells were gated
(CD95 + CD4+ T lymphocytes) and examined for the percentages of cells that stained with annexin V. Alternatively, the MFI of CD38 and HLA-DR was
measured. (A) Both 10 μg/ml and 50 μg/ml Pf extract could dramatically induce the apoptosis of memory CD4+ T cells after 48 hours of coculture
(3.30 ± 0.20% vs. 1.23 ± 0.07% and 4.36 ± 1.10% vs. 1.23 ± 0.07%, respectively, P < 0.001). (B) In this study, 50 μg/ml Pf extract could induce the activation
of memory CD4+ T cells, leading to more CD38 (MFI of 100.50 ± 4.50 vs. 75.27 ± 1.25) and HLA-DR (MFI of 226.00 ± 7.00 vs. 146.00 ± 2.000) expression
on these cells after 48 hours of coculture. (C) A positive correlation was found between the memory CD4+ T cells’ activation level and apoptosis level.
(D) In this study, 50 μg/ml Pf extract could induce more SIV p27 antigen expression after 8 days of coculture (181.70 ± 57.08 vs. 47.11 ± 12.75 pg/ml).
The data in this figure are presented as the means with SD. One-way ANOVA was used to compare the variables in A, B and D. Spearman’s correlation
analysis was used to analyze the relationship between the parameters in C.
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into “short-lived” TEM cells that are more susceptible to
apoptotic signals [41]. Thus, a significantly higher level ofapoptotic TEM cells was observed, but the final outcome
might have been the result of the “indirect apoptosis” of
TCM cells. All of these effects could be associated with the
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on CD4+ T cells, which reflects the activation level of
these cells (Figure 4A–C). Furthermore, the reduction of
the SIV iDNA load in PBMCs was significantly negatively
correlated with increased levels of apoptotic CD4+ TCM
cells and the proportion of HLA-DR +CD38 + CD4+ T
cells during malaria infection (Figures 3C and 4D). We
also found that the SIV iDNA load in PBMCs negatively
correlated with increased levels of apoptotic CD4+ TEM
cells although no significant and this may due to the small
number of animals in present study (Figure 3D). These re-
sults indicated that malaria infection activated and induced
the apoptosis of CD4+ T cells, including memory cells,
thereby leading to the reduction of the SIV reservoirs. The
in vitro study also demonstrated that Pf extract could acti-
vate the memory CD4+ T cells, along with the production
of virion, and could induce the apoptosis of these cells,
suggesting that malaria-induced reservoir purging was
partly related to the Plasmodium itself. This result was
partly consistent with a report by Froebel et al., showing
that malaria antigens could reactivate the replication of en-
dogenous HIV in cells from HIV-infected adults [13].
Histone acetylation in cells is an epigenetic change that
can induce transcriptional activation of HIV-1 provirus
and lead to reservoir purging [25,42]. In the present study,
higher levels of histone acetylation in the PBLs of Pc-
infected monkeys were observed. Activation of NF-κB is
also associated with provirus reactivation [27]; we observed
more NF-κB translocation in PBMCs from the Pc-infected
monkeys. This result was consistent with Chuchard’s re-
port, which showed that PBMCs in malaria patients main-
tained higher levels of NF-κB activation [43]. Our in vitro
studies also confirmed that Pf extracts could induce his-
tone acetylation in resting CD4+ T cells and in latently
HIV-1-infected cells (J-Lat cells) and could activate NF-κB
signaling in monkey PBMCs and in J-Lat cells. Histone
acetylation in cells is not necessarily associated with the
global activation of host cells, which is similar to the
situation induced by the histone deacetylase (HDAC) in-
hibitor VPA [44]. However, reactivation of latent virus
would lead to antigen expression on host cells, which
would induce antigen-specific cytotoxic lymphocyte re-
sponses that would kill the infected cells [4]. Therefore,
histone acetylation and NF-κB activation may also play
important roles in the reduction of the SIV reservoir.
In the present study, we observed that malaria caused
epigenetic changes in monkeys and that this phenomenon
was related to the Plasmodium itself. This result was un-
expected. In particular, many environmental factors, such
as exercise, diet and medications, can cause epigenetic and
developmental epigenetic changes [45,46], whereas our
results indicated that a type of microorganism infection
can cause such changes and this was related to its extract.
Further experiments demonstrated that J-Lat cells andprimary monkey cells had different response patterns in
the presence of Pf extract and that 5 μg/ml Pf extract
could induce a considerable increase in histone acetylation
in J-Lat cells, whereas more Pf extract was needed to in-
duce an increase in histone acetylation in monkey resting
CD4+ T cells (Additional file 3: Figure S3). The differences
in patterns might be attributable to the different prolifera-
tion levels of these two types of cells; J-Lat cells, which are
derived from Jurkat cells, are actively proliferating tumor
cells, and primary monkey cells are non-actively proliferat-
ing cells. The different cell cycle patterns in these two
types of cells may cause different sensitivities to Pf extract,
as it has been shown that different cell cycle patterns may
lead to different sensitivities to certain factors [47,48]. The
present study also showed that the increase in the histone
acetylation level induced by Pf extract was not due to
regulation of HDAC, which has been shown to participate
in regulating the histone acetylation level. This finding in-
dicated that the mechanism of Plasmodium inducing his-
tone acetylation was not similar to that of an HDAC
inhibitor (Additional file 4: Figure S4). However, the exact
mechanism needs to be studied further and in depth. We
do not know whether this phenomenon was Plasmodium
specific, but lipopolysaccharide (LPS) did not induce an
increased level of histone acetylation in primary monkey
cells (Additional file 5: Figure S5), indicating that certain
factors related to bacteria might not be associated with
this phenomenon.
In the present study, we did not observe a delay in viral
rebound in the ART + Pc group compared with the ART
group when ART was terminated at week 75 after SIV in-
oculation (Additional file 1: Figure S1). The re-emergence
or rebound of plasma viremia has also previously been ob-
served following the cessation of ART, despite profoundly
low HIV-1 reservoir levels [49]. Possible reasons for this
observation in rhesus macaques include the following.
First, although the cellular reservoir of SIV decreased dur-
ing malaria infection, the frequency of resting CD4+ T cells
harboring replication-competent SIV remained a large bur-
den for the monkeys. Second, the possibility of the exist-
ence of low levels of SIV replication, the persistence of the
virus in lymphoid tissues or cryptic viral replication in ana-
tomical reservoirs in macaques treated with ART cannot
be eliminated due to the efficiency of the ART regimen.
Conclusions
Altogether, our results indicate that malaria reduced the
volume of the SIV reservoir in monkeys that underwent
ART. We have highlighted the apoptosis of memory
CD4+ T cells during Pc infection, which is a potential
outcome of the activation of these cells induced by mal-
aria. Our in vivo and in vitro results indicate that histone
acetylation and NF-κB activation in resting CD4+ T cells
may also play important roles.
Zhan et al. Retrovirology 2014, 11:112 Page 12 of 17
http://www.retrovirology.com/content/11/1/112As more HIV-1-infected individuals in malaria-endemic
areas receive ART, physicians and researchers should pay
attention to the impact of malaria on the viral reservoir of
these individuals. For example, repeated or longer courses
of malaria infection may occur and more profoundly re-
duce the volume of the viral reservoir in HIV-1-infected
individuals who are receiving effective ART in areas that
are endemic for both HIV-1 and malaria. Several of these
patients may experience virologic benefits. In addition,
based on our previous study [50], modified malaria para-
sites should be explored as vectors for therapeutic HIV-1
vaccine development.
Methods
Animals and study design
The animals were housed and fed according to regula-
tions established by the Guide for the Care and Use of
Laboratory Animals and the Animal Welfare Act at the
Non-human Primate Animal Center of the Guangzhou
Institutes of Biomedicine and Health (GIBH). The animal
experiments performed in this study were approved by
the GIBH Institutional Animal Care and Use Committee
(IACUC) (approval ID 2010008). Figure 1 shows the study
design. All monkeys were treated with ART 15 weeks after
SIV inoculation. The treatment regimen included 30 mg/kg
9-R-(2-phosphonomethoxypropyl) adenine (PMPA) and
20 mg/kg emtricitabine (FTC), administered once daily
intramuscularly (i.m.). Then, 100 mg raltegravir (an inte-
grase inhibitor) was added orally twice per day at week 36.
At week 49, the monkeys in the ART + Pc group were
intravenously inoculated with 2.38 × 107 Pc-infected red
blood cells (RBCs). As controls, monkeys in the ART
group were inoculated with 2.38 × 107 normal RBCs. The
Pc infection was terminated at week 66 by oral chloroquine
administration, and ART was terminated at week 75.
Plasma SIV levels
The levels of plasma SIV RNA were measured by quantita-
tive reverse transcriptase PCR (qRT-PCR), as previously
described [51]. The number of SIV RNA copies was calcu-
lated from a regression curve derived from RNA transcript
standards. This value was divided by the volume of the ex-
tracted plasma specimen to obtain a value in units of SIV
RNA copy equivalents/ml of plasma. In brief, 2000 μl
plasma was centrifuged at 21,000 × g for 3 hours at 4°C,
and 1850 μl supernatant was removed. The virus pellet was
then resuspended completely by vigorous vortexing and
stored at −80°C for RNA isolation. RNA was isolated using
the NucleoSpin viral RNA isolation kit (MACHEREY-
NAGEL, Duren, Germany) according to the manufacturer’s
instructions, except that the virus was incubated in lysis
buffer for 10 minutes at room temperature. The RNA was
eluted in 50 μl RNase-free H2O and frozen in aliquots
at −80°C for subsequent qRT-PCR.Modified real-time RT-PCR was performed to measure
the conserved region of gag in the viral RNA, as described
by Hofmann-Lehmann [52]. The primers and probe spe-
cific for the conserved gag region of SIVmac251 were as
follows: forward, Alu1217, GCAGAGGAGGAAATTAC
CCAG; reverse, SIVgag, ACAATTTTACCCAGGCATT
TAATGTT; and probe Alu1217-P6-carboxyfluorescein,
(FAM)-TCGGGCTTAATGGCAGGTGGACA-BHQ1. The
reactions were performed in 25 μl volumes containing
12.5 μl RNA-direct Realtime PCR Master Mix (Toyobo,
Shanghai, China), 3 mM Mn(OAc)2, 300 nM forward and
reverse primers, 100 nM probe and 5 μl template. The ther-
mal cycling conditions consisted of 30 seconds at 90°C,
20 minutes at 61°C, and 30 seconds at 95°C, followed by
45 cycles of 1 seconds at 95°C, 45 seconds at 60°C and a
plate read. The kinetic PCR amplification data were ana-
lyzed using Bio-Rad CFX Manager software. A standard
curve for the viral RNA was then prepared using serial
dilutions of a synthetic gag transcript in H2O containing
30 μg/ml transfer RNA from Escherichia coli (Sigma). This
544 bp RNA was transcribed in vitro using SP6 RNA Poly-
merase (Takara, Dalian, China) and an EcoRI-digested
PMD-20 T plasmid into which a 461 bp fragment of SIV
gag was inserted. The numbers of RNA copies were calcu-
lated from the concentration determined by the absorbance
at 260 nm. Three replicate reactions were performed for
the samples and standard. The numbers of copies of SIV
RNA in the samples were calculated by interpolation of the
experimentally determined quantification cycle (Cq) value
for the test sample using the transcript-derived linear re-
gression as a standard curve.
Real-time qPCR for SIV iDNA in PBMCs
The amount of SIV iDNA was quantified using modified
Alu-PCR according to the method of Norio et al. [53]. The
primers and probe for the first-round PCR were mAlu-
196 F20, CAGGAGAATCGCTTGAACCC; mAlu-228R19,
GATCTCGGCTCACTGCAAC; and Alu1217-RArt, CAA
TATCATACGCCGAGAAATGTTCTCGGGCTTAATGG.
The reactions were performed in 70 μl volumes containing
25 μl Premix Ex Taq (Takara), 450 nM each primer and
7 μl template. We pre-amplified a 50 μl reaction mixture
under the following thermal cycling conditions: 60 seconds
at 95°C, followed by 12 cycles of 10 seconds at 98°C, 30 sec-
onds at 60°C and 5 minutes at 72°C. The rest of the reac-
tion mixture was stored at 4°C as “non-pre-amplified”
samples. The second-round real-time quantitative multi-
plex PCR was performed using 2 μl of the material from
the pre-amplified or matched mixture of “non-pre-
amplified” samples. The sequences of the primers and
probes were as follows: GAPDH-cF, CCCCATAGGCGAGA
TCCC; GAPDH-cR, CCTCCTGCACTCACCCC; GAPDH-
cP, HEX-CCACGACGTACTCAGCGCCAGCAT-BQ1; Alu
1217-F, GCAGAGGAGGAAATTACCCAG; Alu1217-Art,
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FAM-TCGGGCTTAATGGCAGGTGGACA-BQ1. The re-
actions were performed in 20 μl volumes containing
10 μl THUNDERBIRD Probe qPCR Mix (Toyobo), 300
nM GAPDH-cF and GAPDH-cR, 100 nM GAPDH-cP,
450 nM Alu1217-F and Alu1217-Art, 150 nM Alu1217-
P and 2 μl template. The thermal cycling conditions
consisted of 60 seconds at 95°C, followed by 45 cycles
of 15 seconds at 95°C, 15 seconds at 60°C and a plate
read. The kinetic PCR amplification data were analyzed
using Bio-Rad CFX Manager software. A standard curve
for the viral DNA was prepared using serial dilutions of
cellular DNA extracted from CEMss/SIV/rc cells di-
luted in 104 cells/μl CEMss DNA. Three replicate reac-
tions were performed for both species and the standard.
The numbers of copies of SIV and cell genomes in the
test samples were calculated by interpolation of the ex-
perimentally determined Cq value for the test sample
using the linear regression as a standard curve. The
calculated number of copy equivalents per reaction
mixture is expressed as the number of SIV copies per
105 cells.Measurement of the frequency of resting CD4+ T cells
harboring replication-competent virus
Macaque resting CD4+ T cells were isolated as described
elsewhere [30,54]. Briefly, macaque blood was centri-
fuged through discontinuous density gradients to obtain
PBMCs using 95% Lymphoprep (Fresenius Kabi Norge
AS, Halden, Norway). The PBMCs were labeled with
FITC-conjugated anti-CD4 and APC-conjugated anti-
HLA-DR (BD Biosciences, Franklin Lakes, USA) and
sorted for small HLA-DR-CD4+ cells using a FACSAria
II. Populations of small HLA-DR-CD4+ cells were
isolated with 98–99% purity. The frequency of resting
CD4+ T cells harboring replication-competent virus was
then measured using a co-culture assay in which resting
CD4+ T cells were cultured with the cell line CEM ×
174. This co-culture both activated the macaques’ rest-
ing CD4+ T cells through CD2-CD58 interactions and
expanded virus released from latently infected cells that
became activated, allowing quantification of the size of
the reservoir, as previously described [55,56]. The resting
CD4+ T cells were cultured in a fivefold dilution series
in duplicate, ranging from 1 × 106 to 3.2 × 102 cells per
well. The presence of replication-competent SIV was
then determined by observing SIV outgrowth with p27
after 3 weeks of culture. The co-culture assays were set
up in a limiting-dilution format, and the frequencies of
resting CD4+ T cells harboring replication-competent
virus were determined using the maximum likelihood
method, as previously described [56]. The lower limit of
detection was 0.51 IUPM in the present study.T cell assays, flow cytometry, and monoclonal antibodies
(mAbs)
The following mAbs were used for flow cytometry: anti-
CD3 PerCP, anti-CD4 FITC, anti-CD4 PerCP, anti-CD4 PE-
Cy7, anti-CD8 PerCP, anti-CD8 APC-Cy7, anti-CD28
FITC, anti-CD95 APC, anti-CD195 (anti-CCR5) PE, anti-
Ki67 PE, anti-HLA-DR APC, and anti-HLA-DR FITC (BD
Biosciences). Additionally, annexin V PE was purchased
from BD Biosciences, anti-CD8 APC and anti-CD8 PE were
obtained from Beckman Coulter (CA, USA), and anti-
CD38 FITC was purchased from StemCell Technologies
(Vancouver, Canada). Flow cytometry data were acquired
on a FACSAria II (BD Biosciences). All data were analyzed
using FlowJo software (Tree Star, Ashland, OR, USA).
ELISA for plasma cytokines
Plasma IL-2R, neopterin, IL-6, TNF-α and IL-7 concentra-
tions were assayed by ELISA kits according to the manufac-
turers’ instructions. The kits were obtained from BioLegend
(for IL-2R), Groundwork Biotechnology Diagnosticate and
Alpha Diagnostic International (for neopterin), Mabtech
(for IL-6 and TNF-α) and R&D Systems (for IL-7). Each
plasma sample was analyzed in triplicate.
In vivo NF-κB activation and nuclear transport tests
NF-κB activation and nuclear transport tests were per-
formed using a Nuclear Translocation Assay Kit (catalog
no. SN368, Beyotime, Beijing, China) according to the man-
ufacturers’ instructions. Briefly, PBMCs from monkeys were
collected and then washed once with PBS. These cells were
fixed, transferred to slides, and washed twice with PBS with
Tween-20 (PBST). The cells on the slides were blocked
using PBS with 8% BSA for 1 hour. Next, the cells were in-
cubated with a rabbit anti-human NF-κB p65 antibody
(Beyotime, Beijing, China) at 4°C overnight. The cells were
then stained with a Cy3-labeled anti-rabbit antibody
(Beyotime, Beijing, China), washed with PBST three times
and stained with DAPI at room temperature for 10 minutes.
Finally, the cells were washed with PBST three times and
observed using a confocal microscope (ZEISS LSM 710).
A total of 500 cells on each slide were counted. We spe-
cifically counted cells with NF-κB nuclear staining and
classified them as cells with NF-κB activation.
Measurement of global histone acetylation by flow cytometry
This assay was performed according to the method re-
ported by Archin et al. [25]. Briefly, cells were fixed and
permeabilized with Phosflow Fix Buffer I and Phosflow
Perm Buffer II (BD Biosciences) according to the manufac-
turer’s protocol. The cells were then washed in staining buf-
fer (PBS with 2% FBS and 0.1% sodium azide), blocked with
8% normal goat serum (Invitrogen), and incubated with
anti-AcH3 (1:200 dilution; catalog no. 06–599, Millipore)
or control rabbit IgG in blocking solution for 60 minutes at
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staining buffer and incubated with goat-anti-rabbit IgG
FITC- or Cy3-conjugated secondary antibody (1:200 dilu-
tion; Millipore) in staining buffer for 30 minutes at room
temperature in the dark. Following a final wash, the cells
were analyzed by flow cytometry using a FACSAria II flow
cytometer and FlowJo software (Tree Star).
In vitro experimental design, cells, culture conditions, and
cell treatments
Pf 3d7 or dd2 extract or HZ was added to J-Lat cell cul-
tures to monitor whether the treatment reactivated pro-
virus expression, as indicated by increased GFP expression
and induced histone acetylation or NF-κB activation. We
also performed the same culture assays to monitor the ef-
fect of Pf extracts on resting CD4+ T cells or PBMCs from
rhesus macaques. Pf extract preparation was performed
using saponin to release parasites and an ultrasonic cell
disruptor (Bioruptor UCD-300, Diagenode, Liège, Belgium)
to extract. The concentration was measured based on the
protein concentration. Plasmodium HZ extraction was
performed as follows. Parasites were released from RBCs
by 0.01% saponin lysis and were washed 5–8 times to re-
move RBC debris. Next, the parasites were lyophilized and
extracted with chloroform-methanol (2:1 v/v) to remove
lipids and with chloroform-methanol–water (10:10:3 v/v)
to remove GPIs. After drying, the residue was resuspended
in 100 mM Tris–HCl and 1 mM CaCl2 (pH 7.5) and
digested with pronase to remove proteins and protein-
linked GPIs. The insoluble residue was extracted with
50 mM sodium phosphate (pH 7.2), 4 M guanidine hydro-
chloride, and 0.5% Triton X-100 and was stirred overnight
at 4°C to remove nucleic acids. The residue (insoluble HZ)
was recovered by centrifugation, washed three times with
double-distilled water and once with 80% 1-propanol, and
then dried. The HZ was resuspended in PBS at a final con-
centration of 10 mg/ml and stored at 4°C.
Measurement of activated NF-κB by ELISA
The expression of phospho-NF-κB p65 was tested using a
sandwich ELISA kit (Cell Signaling, USA) according the
manufacturer’s instructions. Each sample was assessed in
triplicate. Briefly, total protein was extracted from 2 × 106
cells/well with different treatments. The protein was then
added to 96-well plates coated with mouse mAb, and the
plates were incubated overnight at 4°C. Next, a phospho-
NF-κB p65 rabbit mAb was added, and the horseradish
peroxidase (HRP) method was used for detection. Each
assay was performed in triplicate.
Measurement of the histone acetylation levels of the
HIV-1 or SIV LTR by ChIP
ChIP analysis was performed according to the online
protocol provided by Millipore and procedures describedelsewhere [57]. Briefly, cells were cross-linked with 1% for-
maldehyde for 10 minutes at 37°C; cross-linking was then
stopped by the addition of a glycine solution. The cells
were washed twice in ice-cold PBS with 1 mM PMSF, re-
suspended in sodium dodecyl sulfate (SDS) lysis buffer
containing 1 mM PMSF and incubated for 10 minutes on
ice. The lysates were sonicated to produce DNA fragments
with an average length of 500–1000 bp using a Bioruptor
D-300 sonicator (Diagenode). The chromatin fragments
from J-Lat 10.6 cells (full-length clones) or rhesus ma-
caques’ PBMCs with different treatments were then diluted
tenfold with immunoprecipitation (IP) dilution buffer.
After pre-clearing with Protein G agarose for 30 minutes
at 4°C with agitation, the material was immunoprecipitated
with 2 μg anti-AcH3 (catalog no. 17–615, Millipore) or
preimmune rabbit IgG (Millipore) via incubation overnight
at 4°C with rotation. To collect the immune complexes,
appropriate amounts of Protein G agarose were added to
each reaction mixture, and the resulting mixtures were ro-
tated for 60 minutes at 4°C. The beads were centrifuged
and then sequentially washed for 5 minutes at 4°C with
each of the following: low-salt immune-complex wash buf-
fer, high-salt immune-complex wash buffer, LiCl immune-
complex wash buffer, and Tris-EDTA buffer. After the
immune complexes were eluted by incubation in elution
buffer (1% SDS and 0.1 M NaHCO3), the supernatants
were isolated and further incubated for 4 hours at 65°C
with appropriate NaCl concentrations to reverse the cross-
linking. Input controls were treated in the same manner.
After reverse cross-linking, DNA was purified using an
Axygen DNA purification kit (Corning Life Sciences,
USA). PCR was performed using HIV-1 or SIV promoter
primers spanning the nuc-1 region of the LTR. The
primers for the HIV-1 LTR or SIV LTR were as follows:
LTR-109 F (5′-TACAAGGGACTTTCCGCTGG-3′) and
LTR + 82R (5′-AGCTTTATTGAGGCTTAAGC-3′). The
DNA products of ChIP were quantitated by real-time PCR
(Bio-Rad CFX96, USA). The phosphorimager data related
to the amounts of PCR product obtained from the immu-
noprecipitated chromatin samples were then compared
with the amounts of PCR product obtained for the input
DNA. The percent of immunoprecipitated LTR was deter-
mined by comparing the cycle threshold values of each re-
action with a standard curve generated from the input
DNA, and these data are reported as the percent of input.
HDAC activity assay
An HDAC activity assay was performed using an HDAC
Activity Colorimetric Assay Kit (BioVision, Palo Alto,
USA) according to the manufacturer’s instructions. Each
sample was assessed in triplicate. Briefly, total protein
was extracted from 2 × 106 cells/well with different treat-
ments, with a final volume of 200 μl in sterile water. Ap-
propriate volumes of protein solution were then added
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strate, HDAC assay buffer and a deacetylated standard;
mixed thoroughly; and incubated in 37°C for 1 hour.
Finally, lysine developer was added to the wells and incu-
bated in 37°C for 30 minutes to produce a chromophore.
SIV p27 antigen assay
An SIV p27 antigen assay was performed using an ELISA
kit (catalog no. 5436, Advanced Bioscience Laboratories,
Kensington, USA) according to the manufacturer’s instruc-
tions. Briefly, cell culture supernatant was first treated with
phosphate buffer with 2.5% Triton-X-100 to release SIV
antigen and then added to 96-well plates coated with a
murine mAb to SIV p27. These plates were incubated at
37°C for 1 hour. Next, HRP-labeled mouse mAb to SIV
p27 was added and incubated at 37°C for 1 hour, and the
HRP method was used for detection. Each assay was per-
formed in triplicate.
Statistical analysis
Variables in the same phase and group were combined to
form a dataset for statistical analysis. Spearman’s correl-
ation analysis was used to analyze the relationship between
the parameters tested. The Mann–Whitney U test was
used to analyze differences between variables obtained
from the in vivo tests. Fisher’s exact test was used for com-
parisons of IUPM under the detection limit, i.e., when the
assay could not generate an exact value. One-way ANOVA
was used in comparisons of variables for in vitro assays.
P < 0.05 was considered significant. GraphPad Prism 6
(GraphPad Software) was used for graphing. Statistical ana-
lyses were performed using SPSS 16. Empower (R) (www.
empowerstats.com, X&Y Solutions, Inc., Boston, MA) and
R (http://www.R-project.org) were used for smooth curve
fitting.
Additional files
Additional file 1: Figure S1. Dynamic changes in plasma SIV viral loads
and certain immunological parameters in the two groups of monkeys
during this study. (A–C) Inoculation with SIV resulted in a peak plasma viral
load between 104 and 107 copies of viral RNA/ml at week 2, and a viral set
point ranging from 103–106 copies of viral RNA/ml of plasma was
established at approximately 12–15 weeks. The monkeys showed a decay of
viremia to below the limit of detection (100 RNA copies/ml) after
approximately 20 weeks of ART. (A) The plasma viral load of the monkeys
during this study. The line shows the median plasma viral load in both
groups during the study. (B) The plasma viral load of each monkey in the
ART group. (C) The plasma viral load of each monkey in the ART + Pc
group. The lines in Additional file 1: Figure S1A, B and C show the dynamic
changes in the plasma viral load in each monkey during the study. (D) The
plasma viral load in each phase. Malaria induced a small increase (not
significant) in the plasma viral load under ART. The horizontal lines indicate
mean values. (E–F) Peripheral blood CD4+ T cells in the two groups of
monkeys. The number of CD4+ T cells dramatically decreased during acute
SIV infection, along with an increase in CD8+ T cells, but both recovered to
baseline levels after control of viral replication. (G–H) SIV infection induced a
degree of immune activation, as represented by an increased proportion ofHLA-DR+CD4+ T cells and HLA-DR+CD8+ T cells. The data in Figure S1E–H
are shown as the means and SD values. Plasma viral loads from different
time points in the same group and phase were combined for statistical
analyses. The Mann-Whitney U test was utilized.
Additional file 2: Figure S2. The impact of malaria on certain
parameters related to activation of the immune system and CD4+ T cells.
(A) The concentrations of plasma cytokines and activity markers, including
IL-2R, IL-7, IL-6 and TNF-α, did not increase during malaria infection under
ART. (B) The ART + Pc group displayed a significantly higher concentration
of plasma neopterin during malaria infection. (C) Pc infection induced the
expression of CCR5 in CD4+ T cells, which also indicated activation of these
cells. (D) A significant positive correlation was found between CD4+ T cell
activation levels and the plasma neopterin concentration. Parameters from
different time points in the same group and phase were combined for
statistical analyses. The Mann–Whitney U test was utilized. Spearman’s
correlation analysis was used to analyze the relationship.
Additional file 3: Figure S3. The dose response to Pf extract in J-Lat
cells and monkey resting CD4+ T cells. In total, 2 × 106 cells/well were
treated with different concentrations of Pf (Pf 3d7) extract. Each
treatment had three replications. Different dose–response patterns were
found between J-Lat cells and primary monkey cells. After 48 hours of
culture, for J-Lat cells, 5 μg/ml Pf extract could induce more histone
acetylation, whereas 50 μg/ml Pf extract could sufficiently induce more
histone acetylation in primary monkey cells. One-way ANOVA was used
to compare the variables in this figure.
Additional file 4: Figure S4. The impact of Pf extract on HDAC activity.
Pf extract did not influence the activity of HDAC in J-Lat cells and
monkey PBMCs after 24 hours of stimulation. In total, 2 × 106 cells/well
were treated with different concentrations of Pf (Pf 3d7) extract. Each
treatment had three replications, and each assay had three replications.
One-way ANOVA was used to compare the variables in this figure.
Additional file 5: Figure S5. The impact of LPS on the histone
acetylation level of primary monkey cells. LPS did not influence the
histone acetylation level of monkey lymphocytes or CD4+ T cells.
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